Functions of High blood pressure, Cholesterol and Heart Meds.

[Guest guest]

PMID: 12888149 [PubMed - indexed for MEDLINE]

--- Prescription Heart Drugs:---Beta blockers and calcium channel blockers are the mainstay ofconventional treatment for high blood pressure, heart disease,angina, and cardiac arrythmias for millions of americans.

 

Calcium channel blockers claim to relax artery walls and lower bloodpressure by blocking the 'entrance' of calcium into the cells!

 

However, they also block some of the "essential functions" of theheart and arteries. Because of the side effects associated with these drugs, manypatients taking calcium channel blockers have experienced a60% higher risk of death from cardiac arrest.

 

An effective "alternative" for the calcium channel blockers isMAGNESIUM. Magnesium is considerably more effective thanprescription drugs. It's primary mode of action is helping toachieve "relaxation" of the smooth muscles of the arteriesand 'reduced stress' on the myocrdium. This is accomplished in a gentle natural way without any accompanying side effects associated with popular prescription drugs (commonly called statins;).

 

Reducing or eliminating excessive amounts of calcium and sodium rich foods while increasing your daily intake of magnesium, potassium and potassium rich foods tends to reduce oxidation of any existing arterial plaque.-------------------------"Beta blockers" are frequently prescribed for high blood pressure.

 

They block the ability of your heart to respond toepinephrine and adrenaline, which actually stimulates your 'pulse'rate and 'blood pressure', elevating both.

 

This tends to bring on a condition where there is an"overall weakening" within the heart itself, so thatblood 'pressure' is *lowered* and heart pain reduced.

 

Beta blockers can be beneficial for 'temporary' relief, but that'snot the way they're prescribed! Virtually every doctor I'm aware ofprescribes them indefinitely!

 

Dr. Julian Whitaker, M.D.

 

www.drwhitaker.com

 

-------------------------Anti-hyperlipidemic drugs (Statins) are givenwith the intention of lowering lipid levels.--- These drugsall have extremely dangerous side effects, and again, there is SCANT 'evidence' that they reduce your overall risk of heart attack! In fact the "fine print" indicates otherwise! Do not rely on orthodox medicine's 'preconceived' assumptions.

 

Statin drugs known as Mevacor, Lipitor and Zocor are high on the list of these popular "lipid-lowering" drugs. Statins reduce the "production" of lipids in the liver and inhibits the manner in which it 'enters' our cells.

 

According to the "Physician's Desk Reference" (PDR), side effects ofthese drugs include liver *toxicity*, muscle "inflammation',gastrointestinal symptoms, and an increased risk of cataractformation.

 

A significant "side effect" of statin drugs not mentioned in the PDRis a "reduction" in your body's production of 'Coenzyme Q10'.

 

Co-Q10 is essential for healthy heart muscles. Co-Q10 is moreprevalent in your heart muscles than any other muscle in our body!!-------------------------

 

Colestid and Questran (resins):

 

absorb bile acids in the intestinal tract and causethem to be excreted, lowering lipid levels circulating in theblood however these same Resins have 'considerable' side effects, namely...

 

constipation, nausea, bloating, and, more seriously,reduced absorption of vitamins A,D, E, and K. Over the long term,these deficiencies may cause bleeding disorders and vision problems!

 

There was actually an "increased" 'death rate' from those takingAtromid-S although it was from 'non-cardiac' causes,primarily forms of *CANCER*!

 

-------------------------A More Safe Natural Approach:-------------------------------We now know that cholesterol-lowering drugs have dangerous sideeffects and there is scant research that they lessen the risk ofheart attack!

 

There are safe alternatives that address the CAUSES ofheart disease, not just the SYMPTOMS!They work to prevent and in some cases even 'reverse' heart disease.

 

A nutrient dense diet rich in organic fruits andvegetables, a high-potency, antioxidant-rich multivitamin regimen,"essential fatty acid" supplementation along with moderate exercisegreatly reduces our risks.

 

www.udoerasmus.com

 

-------------------------Researchers: Diet Cuts Cholesterol as Well as DrugTue Jul 22, 4:21 PM------------------------CHICAGO (Reuters) - The Mediterranean diet can reduce lipid levels about as effectively as lipid loweringdrugs called statins, Canadian researchers said on Tuesday

 

The diet containing natural "plant sterols" found in plants,organic vegetables and fruits, raw almonds, cold-pressed unrefined oils such as olive and sesame oils, in combination with the "viscous fibers" found in organic Oats, barley and psyllium, was creditedwith reducing lipid levels by 29 percent over four weeksin a group of 16 subjects.

 

Another group of study participants who took a daily dose of 20milligrams of the drug *lovastatin* lowered levels by a comparable 31 percent over four weeks.

 

The findings suggested that patients try adietary approach for six to 12 weeks before turning to lipid-lowering drugs,

 

Dr. James Anderson, of the University of Kentucky in Lexington,wrote in an editorial accompanying the study published inthe Journal of the American Medical Association.

 

"Dietary management is an essential part of the treatment for lipiddisorders, although adherence to strict and intensive dietaryinterventions requires motivation by patients, encouragement byphysicians, and, perhaps, counseling by dietitians and nutritionexperts," Anderson wrote.-------------------------High lipids are a known risk factor for cardiovascular disease,and statins reduce the risk of mortality from heart-relatedillnesses (short term) by up to one-third.

 

Unfortunately however, there are many "documented dangers" involved in taking statin drugs.--Study author David Jenkins wrote:

 

"Using the experience gained,further development of a more naturaldietary approach may provide a potentiallyvaluable dietary option for cardiovascular disease risk reduction inprimary prevention."-------------------------Posted: Fri Sep 17, 2004 7:01 pmCarcinogenicity of lipid-lowering drugs.-------------------------.Newman TB, Hulley SB.

 

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve & db=PubMed & list_uids=8531288 & dopt=Abstract

 

Department of Laboratory Medicine,School of Medicine,University of California,San Francisco, USA.

 

OBJECTIVE--To review the findings and implications of studies ofrodent carcinogenicity of lipid-lowering drugs.

 

DATA SOURCES-Summaries of carcinogenicity studies published in the 1992 and 1994Physicians' Desk Reference (PDR),

 

additional information obtained from the US Food and DrugAdministration, and published articles identified by computersearching, bibliographies, and consultation with experts.

 

STUDY SAMPLE--We tabulated 'rodent carcinogenicity' data from the 1994PDR for all drugs listed as "hypolipidemics."

 

For comparison, we selected a stratified random sample ofanti-hypertensive drugs.

 

We also reviewed methods and interpretation of carcinogenicitystudies in rodents and results of clinical trials in humans.

 

DATA SYNTHESIS--All members of the two most popular classes of lipid-lowering drugs (the fibrates and the statins)cause cancer in rodents,in some cases at levels of animal exposureclose to those prescribed to humans.

 

CONCLUSIONS--Extrapolation of this evidence of carcinogenesis fromrodents to humans is an uncertain process.Longer-term clinical trials and careful postmarketing surveillanceduring the next several decades are needed to determine whetherlipid-lowering drugs cause cancer in humans.

 

In the meantime, the results of experiments in animals and humanssuggest that lipid-lowering drug treatment,especially with the fibrates and statins,should be avoided except in patients at high short-term riskof coronary heart disease.

 

Publication Types:ReviewReview Literature

 

PMID: 8531288 [PubMed-----------------------------

 

"Calcified Plaque" burden remains 'unchanged' by Statin drugs-------------------------

 

Relation of aggressiveness of lipid-lowering treatment to changes incalcified plaque burden by electron beam tomography.

 

Hecht HS, Harman SM.

 

Beth Israel Medical Center, New York, New York 10003, USA.hhe--------------------------The comparative effects of more versus less aggressive low-densitylipoprotein (LDL) lowering (to </=80 vs >80 mg/dl) oncalcified coronary plaque progression by electron beam tomographywere evaluated in 182 consecutive asymptomatic patients after 1.2years of treatment with statins alone or in combination with niacin.

 

Despite the greater improvement in lipids in the </=80 versus >80mg/dl groups, there were no differences in 'calcified plaque'progression (9.3%/year vs 9.1%/year).

 

We conclude that, with respect to LDL lipid lowering withStatins, the "lower is better" theory is not supported by changesin calcified plaque progression.

 

Publication Types:Clinical TrialPMID: 12888149 [PubMed - indexed for MEDLINE]_________________